微创单支冠状动脉旁路移植术较传统胸骨切开术降低并发症与死亡率
基于美国胸外科医师学会(STS)全国数据库2014年1月至2016年12月单支冠状动脉旁路移植术(CABG)患者数据,倾向加权比较微创非胸骨切开CABG(MICABG)与传统CABG的围术期结局。MICABG与住院死亡率、30天死亡率、通气时间、住院延长、深部伤口感染、输血及STS复合并发症均降低相关,主要不良心脏事件与桥血管闭塞无差异。
要点
- 单支病变CABG中MICABG与住院及30天死亡率降低相关
- MICABG与深部伤口感染、输血和复合并发症减少相关
- 两组主要不良心脏事件与桥血管闭塞无差异
核心结论
- MICABG较传统胸骨切开CABG与更低的死亡率和围术期并发症相关,可能在单支病变治疗中占有一席之地。
研究设计与样本
- 回顾性查询STS全国数据库2014年1月至2016年12月单支CABG患者,排除同期或急诊手术,采用倾向加权比较并校正机构间差异。
- 共纳入12406例符合条件的患者,其中2688例(21.7%)接受MICABG,9818例(78.3%)接受传统CABG。
主要发现
- MICABG与住院死亡率降低相关(OR=0.32,绝对降低0.91%,P<0.0001),30天死亡率降低(OR=0.51,绝对降低0.88%,P=0.001)。
- MICABG与通气时间缩短(8.62 vs 12.6小时,P<0.0001)、住院延长减少(OR=0.77,绝对降低1.6,P=0.043)相关。
- MICABG与深部伤口感染减少(OR=0.33,绝对降低0.68%,P<0.004)、术后输血减少(OR=0.52,绝对降低7.7%,P<0.0001)相关。
- MICABG与STS复合并发症降低相关(OR=0.72,绝对降低1.19%,P=0.008)。
- 仅纳入非体外循环左乳内动脉-左前降支CABG的亚组分析显示类似结果;主要不良心脏事件和桥血管闭塞两组无差异。
临床怎么用
- 对于单支冠状动脉病变需行CABG者,可考虑MICABG以减少围术期死亡、感染、输血和住院延长,同时关注桥血管通畅性。
局限性
- 为基于STS数据库的回顾性分析,非随机对照,可能存在选择偏倚和未测混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to describe the safety and clinical benefits of minimally invasive, nonsternotomy coronary artery bypass grafting (MICABG) using data from The Society of Thoracic Surgeons (STS) National Database. BACKGROUND: MICABG has gained popularity, owing to expected lower perioperative morbidity and shorter recovery. Despite this, concerns remain regarding anastomotic quality and the validity of proposed perioperative benefits. METHODS: We queried the STS National Database for all patients who underwent single-vessel coronary artery bypass grafting (CABG) from January 2014 to December 2016 to compare outcomes of MICABG with conventional CABG. Patients who underwent concomitant or emergent procedures were excluded. Propensity-weighted cohorts were compared by operative approach with adjustment for variability across institutions. RESULTS: Of 12,406 eligible patients, 2688 (21.7%) underwent MICABG, and 9818 (78.3%) underwent conventional CABG. Propensity weighting produced excellent balance in patient characteristics, including completeness of revascularization, body mass index, and STS predictive risk scores. MICABG was associated with significant reduction of in-hospital mortality [odds ratio (OR)=0.32, absolute reduction (AR)=0.91%, P <0.0001]; 30-day mortality (OR=0.51, AR=0.88%, P =0.001), duration of ventilation (8.62 vs 12.6 hours, P <0.0001), prolonged hospitalization (OR=0.77, AR=1.6, P =0.043), deep wound infection (OR=0.33, AR=0.68, P <0.004), postoperative transfusions (OR=0.52, AR=7.7%, P <0.0001), and STS composite morbidity (OR=0.72, AR=1.19%, P =0.008). Subgroup analysis of only off-pump left internal mammary artery-left anterior descending CABG showed similar findings. Major adverse cardiac events and graft occlusion did not differ between groups. CONCLUSIONS: MICABG is associated with lower mortality and perioperative morbidity compared with conventional sternotomy CABG. MICABG may have a role in treating single-vessel disease.
引用
- Cain MT, Joyce DL, Szabo A, et al. Reduced Morbidity and Mortality Associated With Minimally Invasive Single-vessel Coronary Artery Bypass Compared With Conventional Sternotomy. Ann Surg. 2022. PMID: 35797604. doi:10.1097/SLA.0000000000005511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。